CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 119 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,320,500 | -26.7% | 6,450,000 | -2.3% | 1.17% | -29.7% |
| Q2 2023 | $11,352,000 | +23.4% | 6,600,000 | +8.3% | 1.67% | +21.9% |
| Q1 2023 | $9,200,478 | +63.8% | 6,093,032 | +73.6% | 1.37% | +68.0% |
| Q4 2022 | $5,616,712 | +10.7% | 3,510,445 | +0.3% | 0.82% | +31.2% |
| Q3 2022 | $5,075,000 | +163.0% | 3,500,000 | +231.9% | 0.62% | +112.3% |
| Q2 2022 | $1,930,000 | +192.4% | 1,054,673 | +592.3% | 0.29% | +120.3% |
| Q4 2021 | $660,000 | -12.1% | 152,345 | +35.0% | 0.13% | -2.2% |
| Q3 2020 | $751,000 | -69.9% | 112,880 | -62.4% | 0.14% | -44.0% |
| Q2 2020 | $2,499,000 | +8.6% | 300,000 | 0.0% | 0.24% | -24.8% |
| Q1 2020 | $2,301,000 | – | 300,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |